It is now well known that rheumatoid arthritis (RA) is strongly associated with HLA DR4,'-3 though a recent study suggested that this may be so only in the seropositive group.4 Whether the severity of disease is also under genetic control is still unresolved. Thus high titres of IgM rheumatoid factor and the presence of nodules, features conventionally associated with poor prognosis, have been shown to be associated with DR3,3 while it has been suggested that DR4 may be a genetic marker predisposing to the production of IgM rheumatoid factor.4
We decided therefore to investigate the role of DR2, 3, and 4 There was a similar discrepancy in the presence of Sjogren's syndrome, which was present in 31 out of 65 patients tested. Only 4 patients with DR2 out of a total of 16 were affected, half the expected frequency (X2 = 4 0, p<0 05) ( Table 3) .
Radiological joint involvement. The x-ray scores were divided into groups above or below 10 years of disease duration and more or less than 10 erosions in order to obtain some conformity within the groups. There were only 3 patients out of 32 with a disease duration of greater than 10 years and a score of less than 10, and all were erosive (Table 4 ). All 3 were DR4-positive and one was DR2,4-positive. However, there is a significant lack of patients in the DR2-positive group with a disease duration of less than 10 years and an erosive score of greater than 10 (p< 0 025) and a nonsignificant excess in those with a score of less than 10 ( Table 5 ). 6 , and DR2 1 6 + 2-5). Clinical joint involvement. The most interesting findings were those relating to present joint scores, as the DR2-positive group appeared to be markedly less active than the DR3 or DR4 groups, but reaching significance only against DR3 (p = <0 025) (Fig. 1) .
Though a past total joint score relies on memory, this showed a trend, being highest in the DR3 group, intermediate in the DR4 group, and lowest in the DR2 group (Table 6 ). The number of patients who had only DR2 or DR3 was very small, but less than one joint was involved on average in the DR2-positive (DR3,DR4-negative) group compared with 13 in the DR3-positive (DR2,4-negative) group.
The worst scores were present in the seven patients who possessed DR3 and DR4, their past score being 45 and present 20 (Table 6 ).
Discussion
Our results suggest that the presence of HLA DR2, which has a reduced prevalence in patients with rheumatoid arthritis,3 5 may be an indicator of less severe disease and of a better response to second-line drug therapy. The presence of nodules and Sjogren's syndrome was less common in this group, their present joint scores were markedly superior to the patient with HLA DR3 or 4, and radiographic destruction in the first 10 years of disease was also less severe. This latter result may reflect the present enthusiasm for treating patients with gold or penicillamine earlier in their disease, so that patients with a disease duration of greater than 10 years may not have had the benefit of them in time to slow their erosive damage. If a protective effect is present, this may not help beyond the first few years of the disease. 
